Modulated Calcium Homeostasis and Release Events Under Atrial Fibrillation and Its Risk Factors: A Meta-Analysis.

Show simple item record

dc.contributor.author Fong, Sarah Pei Ting
dc.contributor.author Agrawal, Shaleka
dc.contributor.author Gong, Mengqi
dc.contributor.author Zhao, Jichao
dc.coverage.spatial Switzerland
dc.date.accessioned 2022-09-30T00:59:59Z
dc.date.available 2022-09-30T00:59:59Z
dc.date.issued 2021-01
dc.identifier.citation (2021). Frontiers in Cardiovascular Medicine, 8, 662914-.
dc.identifier.issn 2297-055X
dc.identifier.uri https://hdl.handle.net/2292/61488
dc.description.abstract <b>Background:</b> Atrial fibrillation (AF) is associated with calcium (Ca<sup>2+</sup>) handling remodeling and increased spontaneous calcium release events (SCaEs). Nevertheless, its exact mechanism remains unclear, resulting in suboptimal primary and secondary preventative strategies. <b>Methods:</b> We searched the PubMed database for studies that investigated the relationship between SCaEs and AF and/or its risk factors. Meta-analysis was used to examine the Ca<sup>2+</sup> mechanisms involved in the primary and secondary AF preventative groups. <b>Results:</b> We included a total of 74 studies, out of the identified 446 publications from inception (1982) until March 31, 2020. Forty-five were primary and 29 were secondary prevention studies for AF. The main Ca<sup>2+</sup> release events, calcium transient (standardized mean difference (SMD) = 0.49; <i>I</i> <sup>2</sup> = 35%; confidence interval (CI) = 0.33-0.66; <i>p</i> < 0.0001), and spark amplitude (SMD = 0.48; <i>I</i> <sup>2</sup> = 0%; CI = -0.98-1.93; <i>p</i> = 0.054) were enhanced in the primary diseased group, while calcium transient frequency was increased in the secondary group. Calcium spark frequency was elevated in both the primary diseased and secondary AF groups. One of the key cardiac currents, the L-type calcium current (I<sub>CaL</sub>) was significantly downregulated in primary diseased (SMD = -1.07; <i>I</i> <sup>2</sup> = 88%; CI = -1.94 to -0.20; <i>p</i> < 0.0001) and secondary AF groups (SMD = -1.28; <i>I</i> <sup>2</sup> = 91%; CI = -2.04 to -0.52; <i>p</i> < 0.0001). Furthermore, the sodium-calcium exchanger (I<sub>NCX</sub>) and NCX1 protein expression were significantly enhanced in the primary diseased group, while only NCX1 protein expression was shown to increase in the secondary AF studies. The phosphorylation of the ryanodine receptor at S2808 (pRyR-S2808) was significantly elevated in both the primary and secondary groups. It was increased in the primary diseased and proarrhythmic subgroups (SMD = 0.95; <i>I</i> <sup>2</sup> = 64%; CI = 0.12-1.79; <i>p</i> = 0.074) and secondary AF group (SMD = 0.66; <i>I</i> <sup>2</sup> = 63%; CI = 0.01-1.31; <i>p</i> < 0.0001). Sarco/endoplasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) expression was elevated in the primary diseased and proarrhythmic drug subgroups but substantially reduced in the secondary paroxysmal AF subgroup. <b>Conclusions:</b> Our study identified that I<sub>CaL</sub> is reduced in both the primary and secondary diseased groups. Furthermore, pRyR-S2808 and NCX1 protein expression are enhanced. The remodeling leads to elevated Ca<sup>2+</sup> functional activities, such as increased frequencies or amplitude of Ca<sup>2+</sup> spark and Ca<sup>2+</sup> transient. The main difference identified between the primary and secondary diseased groups is SERCA expression, which is elevated in the primary diseased group and substantially reduced in the secondary paroxysmal AF subgroup. We believe our study will add new evidence to AF mechanisms and treatment targets.
dc.format.medium Electronic-eCollection
dc.language eng
dc.publisher Frontiers
dc.relation.ispartofseries Frontiers in cardiovascular medicine
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject Ca2+ sparks
dc.subject atrial fibrillation
dc.subject calcium handling
dc.subject calcium release events
dc.subject primary AF prevention
dc.subject secondary AF prevention
dc.subject Heart Disease
dc.subject Cardiovascular
dc.subject Prevention
dc.title Modulated Calcium Homeostasis and Release Events Under Atrial Fibrillation and Its Risk Factors: A Meta-Analysis.
dc.type Journal Article
dc.identifier.doi 10.3389/fcvm.2021.662914
pubs.begin-page 662914
pubs.volume 8
dc.date.updated 2022-08-01T03:55:44Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 34355025 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/34355025
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Systematic Review
pubs.subtype systematic-review
pubs.elements-id 863369
pubs.org-id Bioengineering Institute
pubs.org-id ABI Associates
dc.identifier.eissn 2297-055X
pubs.record-created-at-source-date 2022-08-01
pubs.online-publication-date 2021-07-20


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics